Truist Financial Lowers OrthoPediatrics (NASDAQ:KIDS) Price Target to $35.00

OrthoPediatrics (NASDAQ:KIDS) had its price target dropped by Truist Financial from $38.00 to $35.00 in a research note issued on Tuesday, Benzinga reports. The firm currently has a “hold” rating on the stock. Truist Financial’s price objective indicates a potential downside of 1.10% from the stock’s current price.

A number of other research firms have also recently issued reports on KIDS. Needham & Company LLC lifted their price target on OrthoPediatrics from $37.00 to $42.00 and gave the company a “buy” rating in a report on Tuesday, May 7th. JMP Securities reiterated a “market outperform” rating and set a $50.00 target price on shares of OrthoPediatrics in a research report on Tuesday, May 7th.

OrthoPediatrics Stock Up 0.1 %

Shares of NASDAQ:KIDS opened at $35.39 on Tuesday. The company has a market capitalization of $843.34 million, a PE ratio of -36.86 and a beta of 1.19. The company has a debt-to-equity ratio of 0.03, a quick ratio of 1.99 and a current ratio of 4.45. The company’s fifty day moving average is $31.18 and its 200-day moving average is $29.60. OrthoPediatrics has a 52 week low of $23.10 and a 52 week high of $45.96.

OrthoPediatrics (NASDAQ:KIDS) last released its quarterly earnings results on Monday, May 6th. The company reported ($0.30) EPS for the quarter, beating analysts’ consensus estimates of ($0.42) by $0.12. The firm had revenue of $44.69 million for the quarter, compared to analyst estimates of $41.63 million. OrthoPediatrics had a negative net margin of 13.58% and a negative return on equity of 5.12%. Equities research analysts predict that OrthoPediatrics will post -1.2 earnings per share for the current fiscal year.

Hedge Funds Weigh In On OrthoPediatrics

Several hedge funds have recently added to or reduced their stakes in KIDS. CWM LLC lifted its position in OrthoPediatrics by 16,283.3% during the 4th quarter. CWM LLC now owns 983 shares of the company’s stock valued at $32,000 after purchasing an additional 977 shares during the period. International Assets Investment Management LLC lifted its holdings in OrthoPediatrics by 3,151.4% in the fourth quarter. International Assets Investment Management LLC now owns 1,203 shares of the company’s stock valued at $37,000 after buying an additional 1,166 shares during the period. EntryPoint Capital LLC lifted its holdings in OrthoPediatrics by 56.9% in the first quarter. EntryPoint Capital LLC now owns 2,783 shares of the company’s stock valued at $81,000 after buying an additional 1,009 shares during the period. SG Americas Securities LLC bought a new position in OrthoPediatrics in the second quarter valued at approximately $110,000. Finally, State Board of Administration of Florida Retirement System acquired a new stake in OrthoPediatrics during the 1st quarter worth $178,000. Institutional investors own 69.05% of the company’s stock.

OrthoPediatrics Company Profile

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products.